Green Bone: Biomimetic – Reabsorbable – Bamboo-derived bone graft scaffold




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Green Bone: Biomimetic – Reabsorbable – Bamboo-derived bone graft scaffold
Released on: January 10, 2017. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    GREENBONE ORTHO SRL wants to become a worldwide leader for bone regeneration by providing innovative and easy to use bio-inspired solutions that will help cure severe diseases.
  • Summary
  • Participants
  • Company
GREENBONE ORTHO SRL wants to become a worldwide leader for bone regeneration by providing innovative and easy to use bio-inspired solutions that will help cure severe diseases. The primary goal of GREENBONE is to develop a highly innovative bone implant, to generate biomimetic – reabsorbable – Bamboo-derived bone graft scaffold suitable to address non-union fractures and other very nasty skeleton damages.
Michele Marzola
GreenBone Ortho srl is a start up founded in 2014 and located in Faenza (Italy). GreenBone is developing a highly innovative, bone regenerating, load-bearing implants to treat severe fractures and conditions such as trauma and tumours that result in extensive bone loss. The company’s patented technology transforms Bamboo into an established, widely used biomaterial, hydroxyapatite, to provide a bone graft scaffold with unique and never achieved so far mechanical strength, weight bearing and bone regeneration properties needed for large implants. New functional bone formation with GreenBone has been demonstrated in vitro and in vivo. GreenBone will begin human studies early 2017 in patients with non-healing (non-union) critical size fractures. The company is led by a world class team that has advanced multiple orthopaedic products from bench-to-market. GreenBone technology was conceived and developed by a research group at ISTEC-CNR in Faenza (Institute of Science and Technology for Ceramics). First patent, filed in many territories, has been already granted in EU and China. Two new patents recently submitted. GreenBone Ortho srl and CNR entered a world wide exclusive license agreement (including right to acquire). GreenBone closed a first round of investments for 3 million Euro from ZernikeMeta Ventures, Italian Angels for Growth (IAG) and some private Italian and foreign investors.